Autoantibodies Recognizing Secondary NEcrotic Cells Promote Neutrophilic Phagocytosis and Identify Patients With Systemic Lupus Erythematosus
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Frontiers in Immunology 9 (2018).
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2018
- Urheber
-
Biermann, Mona H. C.
Boeltz, Sebastian
Pieterse, Elmar
Knopf, Jasmin
Rech, Jürgen
Bilyy, Rostyslav
Vlag, Johan van der
Tincani, Angela
Distler, Jörg H. W.
Krönke, Gerhard
Schett, Georg Andreas
Herrmann, Martin
Muñoz, Luis E.
- URN
-
urn:nbn:de:bvb:29-opus4-117532
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Biermann, Mona H. C.
- Boeltz, Sebastian
- Pieterse, Elmar
- Knopf, Jasmin
- Rech, Jürgen
- Bilyy, Rostyslav
- Vlag, Johan van der
- Tincani, Angela
- Distler, Jörg H. W.
- Krönke, Gerhard
- Schett, Georg Andreas
- Herrmann, Martin
- Muñoz, Luis E.
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2018
Ähnliche Objekte (12)
The extracellular release of DNA and HMGB1 from Jurkat T cells during in vitro necrotic cell death
Fibroblast activation protein inhibitor PET/CT as an emerging diagnostic modality in interstitial lung disease and other fibrotic conditions
Pharmacological inhibition of porcupine as monotherapy or in combination with ruxolitinib, ibrutinib or belumosudil in experimental sclerodermatous chronic graft-versus-host disease
Long-term preoperative glycemic control restored the perioperative neutrophilic phagocytosis activity in diabetic mice
IgG autoantibodies bound to surfaces of necrotic cells and complement C4 comprise the phagocytosis promoting activity for necrotic cells of SLE sera
Tie2 as a novel key factor of microangiopathy in systemic sclerosis
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
Tie2 as a novel key factor of microangiopathy in systemic sclerosis
IgG autoantibodies bound to surfaces of necrotic cells and complement C4 comprise the phagocytosis promoting activity for necrotic cells of systemic lupus erythaematosus sera
Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis
Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis
Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects
The extracellular release of DNA and HMGB1 from Jurkat T cells during in vitro necrotic cell death
Fibroblast activation protein inhibitor PET/CT as an emerging diagnostic modality in interstitial lung disease and other fibrotic conditions
Pharmacological inhibition of porcupine as monotherapy or in combination with ruxolitinib, ibrutinib or belumosudil in experimental sclerodermatous chronic graft-versus-host disease
Long-term preoperative glycemic control restored the perioperative neutrophilic phagocytosis activity in diabetic mice
IgG autoantibodies bound to surfaces of necrotic cells and complement C4 comprise the phagocytosis promoting activity for necrotic cells of SLE sera
Tie2 as a novel key factor of microangiopathy in systemic sclerosis
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
Tie2 as a novel key factor of microangiopathy in systemic sclerosis
IgG autoantibodies bound to surfaces of necrotic cells and complement C4 comprise the phagocytosis promoting activity for necrotic cells of systemic lupus erythaematosus sera
Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis
Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis
Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects
The extracellular release of DNA and HMGB1 from Jurkat T cells during in vitro necrotic cell death
Fibroblast activation protein inhibitor PET/CT as an emerging diagnostic modality in interstitial lung disease and other fibrotic conditions
Pharmacological inhibition of porcupine as monotherapy or in combination with ruxolitinib, ibrutinib or belumosudil in experimental sclerodermatous chronic graft-versus-host disease
Long-term preoperative glycemic control restored the perioperative neutrophilic phagocytosis activity in diabetic mice
IgG autoantibodies bound to surfaces of necrotic cells and complement C4 comprise the phagocytosis promoting activity for necrotic cells of SLE sera
Tie2 as a novel key factor of microangiopathy in systemic sclerosis
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
Tie2 as a novel key factor of microangiopathy in systemic sclerosis
IgG autoantibodies bound to surfaces of necrotic cells and complement C4 comprise the phagocytosis promoting activity for necrotic cells of systemic lupus erythaematosus sera
Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis
Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis